In the second part of our exclusive interview with Ecofibre CEO Eric Wang, he outlines his hopes for the schedule 3, over-the-counter market in Australia and the firm’s ambitions for its Ananda Food division.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

The Australian over-the-counter market will provide CBD companies with the most significant sales opportunity for years, Ecofibre chief executive Eric Wang has said, as the company embarks on its phase III clinical trial for sleep-related conditions.

Steve has reported for a number of consumer and B2B titles over a journalism career spanning more than three decades. He is a regulator contributor to health journal, The Medical Republic, writing on...